394 related articles for article (PubMed ID: 19106146)
1. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.
Perrino M; Vannucchi G; Vicentini L; Cantoni G; Dazzi D; Colombo C; Rodari M; Chiti A; Beck-Peccoz P; Fugazzola L
Endocr Relat Cancer; 2009 Mar; 16(1):201-10. PubMed ID: 19106146
[TBL] [Abstract][Full Text] [Related]
2. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
3. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
4. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
5. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
7. Routine bilateral central lymph node clearance for papillary thyroid cancer.
Sadowski BM; Snyder SK; Lairmore TC
Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
[TBL] [Abstract][Full Text] [Related]
8. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
10. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
Giles Senyurek Y; Tunca F; Boztepe H; Alagöl F; Terzioglu T; Tezelman S
Surgery; 2009 Dec; 146(6):1188-95. PubMed ID: 19958948
[TBL] [Abstract][Full Text] [Related]
11. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
13. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
14. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
16. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological analysis of central compartment dissection in patients with papillary thyroid cancer with negative clinical lymph node metastasis].
Fu JY; Wu Y; Wang ZY; An Y; Sun TQ; Xiang J
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):470-2. PubMed ID: 17686305
[TBL] [Abstract][Full Text] [Related]
18. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
[TBL] [Abstract][Full Text] [Related]
19. Predictors of thyroid tumor aggressiveness.
Clark OH
West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
